VanEck Associates
NHI icon

VanEck Associates’s National Health Investors NHI Stock Holding History

VanEck Associates’s Portfolio NHI Stock Details NHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
13,512
+231
+2% +$17.7K ﹤0.01% 1126
2026
Q1 		$1.07M Buy
13,281
+686
+5% +$57.1K ﹤0.01% 1076
2025
Q4 		$962K Buy
12,595
+1,313
+12% +$101K ﹤0.01% 1082
2025
Q3 		$897K Buy
11,282
+1,098
+11% +$82.2K ﹤0.01% 1104
2025
Q2 		$714K Buy
10,184
+1,515
+17% +$111K ﹤0.01% 1110
2025
Q1 		$640K Buy
8,669
+710
+9% +$50.1K ﹤0.01% 1111
2024
Q4 		$552K Buy
7,959
+767
+11% +$58.3K ﹤0.01% 1120
2024
Q3 		$550K Buy
7,192
+788
+12% +$60.7K ﹤0.01% 1082
2024
Q2 		$434K Buy
6,404
+416
+7% +$26.7K ﹤0.01% 1105
2024
Q1 		$376K Buy
5,988
+137
+2% +$7.73K ﹤0.01% 1097
2023
Q4 		$327K Buy
5,851
+962
+20% +$50.9K ﹤0.01% 1099
2023
Q3 		$251K Buy
4,889
+202
+4% +$10.6K ﹤0.01% 1126
2023
Q2 		$246K Buy
4,687
+119
+3% +$6.13K ﹤0.01% 1148
2023
Q1 		$236K Buy
4,568
+237
+5% +$12.9K ﹤0.01% 1138
2022
Q4 		$226K Buy
4,331
+1,853
+75% +$102K ﹤0.01% 1060
2022
Q3 		$140K Sell
2,478
-1,525
-38% -$96.1K ﹤0.01% 1114
2022
Q2 		$243K Buy
4,003
+84
+2% +$4.78K ﹤0.01% 1035
2022
Q1 		$231K Buy
3,919
+514
+15% +$29.3K ﹤0.01% 1076
2021
Q4 		$196K Buy
3,405
+1,365
+67% +$75.5K ﹤0.01% 1114
2021
Q3 		$109K Buy
2,040
+275
+16% +$17.2K ﹤0.01% 1134
2021
Q2 		$118K Sell
1,765
-46
-3% -$3.21K ﹤0.01% 1072
2021
Q1 		$131K Buy
1,811
+82
+5% +$5.72K ﹤0.01% 983
2020
Q4 		$120K Buy
1,729
+431
+33% +$27.4K ﹤0.01% 891
2020
Q3 		$78K Buy
1,298
+247
+24% +$15.2K ﹤0.01% 905
2020
Q2 		$64K Buy
1,051
+530
+102% +$29.1K ﹤0.01% 891
2020
Q1 		$26K Buy
521
+271
+108% +$20.6K ﹤0.01% 909
2019
Q4 		$20K Buy
+250
New +$20.5K ﹤0.01% 918

Other funds holding NHI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

VanEck Associates's NHI Position: Q2 2026 in Review

VanEck Associates increased its National Health Investors (NHI) stake by 1.7% in Q2 2026, buying an estimated $17.7K and bringing the position to 13,512 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1126.

VanEck Associates first reported a position in NHI in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.07M in Q1 2026. 303 funds tracked by Wall St. Rank hold NHI as of Q2 2026.

  • VanEck Associates held 13,512 shares of National Health Investors worth $1.03M as of Q2 2026.
  • VanEck Associates bought 231 National Health Investors shares in Q2 2026, an estimated $17.7K.
  • National Health Investors made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1126 holding.
  • VanEck Associates first reported a position in National Health Investors in Q4 2019 and has held it in 27 quarters since.
  • VanEck Associates's National Health Investors position peaked at $1.07M in Q1 2026.
  • 303 funds tracked by Wall St. Rank held National Health Investors as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.